Hypertension Patients’ Adherence in Chronic Disease Care Program at Public Health Center
DOI:
https://doi.org/10.61841/h1mk3709Keywords:
Prolanis, Hypertension, Blood Pressure, Patients’ ObedienceAbstract
Hypertension has a significant role in hypertension management. The hypertension control program can be performed through four Prolanis (chronic disease management program) programs and four hypertension management obedience programs.
Objective: Explaining the correlation between the patients’ obedience following Prolanis and the patients' hypertension.
Method: This study employed a quantitative design with the correlation method. The respondents were twenty-four hypertension Prolanis participants, with total population sampling method. The dependent variables were Prolanis and patients’ obedience to join Prolanis. The independent variable was hypertension. The data were collected by using special data, a dietary compliance questionnaire, physical activity (Baecke), medication (MMA-8) and medical records. The statistic test employed Chi-square with Fisher exact as an alternative test with a significant value of less than 0.05.
Result: There was a correlation between Prolanis implementation and hypertension patients’ obedience.
Conclusion: Half of the patients are obedient in implementing Prolanis.Therefore, the obedient patients and the disobedient patients are of equal numbers. There is a significant correlation between Prolanis implementation and patients with hypertension. The patients’ compliance in implementing Prolanis and blood pressure in patients with hypertension have a significant correlation. The assessment of the four patient obediences in implementing Prolanis in hypertension needs to be performed, considering the importance of maintaining normal blood pressure and preventing the complications.
Downloads
References
[1] Mufarrihah M, Setiawan CD, Wathaniah N, Rahmaniah A, Maharani PA, Mahmudah AS, et al. The Influence of Medication Days’ Supply on Adherence and Cost of Hypertensive Patients at Primary Health Care Centre. Indones J Pharm. 2017;28(4):213.
[2] Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global Burden of Hypertension: Analysis of Worldwide Data. Lancet. 2005;365(9455):217–23.
[3] Sarwanto S, Wilujeng LK, Rukmini R. Prevalensi Penyakit Hipertensi Penduduk di Indonesia dan Faktor yang Berrisiko. Bul Penelit Sist Kesehat. 2009;12(2).
[4] Méndez-Chacón E, Santamaría-Ulloa C, and Rosero-Bixby L. Factors Associated with Hypertension Prevalence, Unawareness, and Treatment among Costa Rican Elderly. BMC Public Health. 2008;8(1):275.
[5] Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Boehm M, et al. 2013 ESH/ESC Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Blood Press. 2013;22(4):193-278.
[6] Kesehatan B. Panduan Praktis PROLANIS (Program pengelolaan penyakit kronis). Jakarta BPJS Keseharan. 2014;
[7] Park SK, Lee D-Y, Kim WJ, Lee SY, Park HS, Kim HW, et al. Comparing the Clinical Efficacy of Resting and Antihypertensive Medication in Patients of Hypertensive Urgency: Randomized, Control Trial. J Hypertens. 2017;35(7):1474–80.
[8] Ibrahim MM, Damasceno A. Hypertension in Developing Countries. Lancet. 2012;380(9841):611–9.
[9] Akoko BM, Fon PN, Ngu RC, Ngu KB. Knowledge of Hypertension and Compliance with Therapy Among Hypertensive Patients in the Bamenda Health District of Cameroon: a Cross-sectional Study. Cardiol Ther. 2017;6(1):53–67.
[10] Ahmad M, Rachmawaty R, Sjattar EL, Yusuf S. Prolanis Implementation Effective to Control Fasting Blood Sugar, HBA1C, and Total Cholesterol Levels in Patients with Type 2 Diabetes. J Ners. 2017;12(1):88–98.
[11] Voorham J, Haaijer-Ruskamp FM, Wolffenbuttel BHR, Stolk RP, Denig P. Medication Adherence Affects Treatment Modifications in Patients with Type 2 Diabetes. Clin Ther. 2011;33(1):121–34.
[12] Green LW, Kreuter MW, Deeds SG, Partridge KB, Bartlett E. Health Education Planning: a Diagnostic Approach. 1980;
[13] Nursalam S. Metodologi Penelitian Ilmu Keperawatan Pendekatan Praktis. Jakarta Salemba Med. 2013;
[14] Wessels MMS, te Lintelo M, Vriezinga SL, Putter H, Hopman EG, Mearin ML. Assessment of dietary compliance in Celiac Children Using a Standardized Dietary Interview. Clin Nutr. 2018;37(3):1000–4.
[15] Sadeghisani M, Manshadi FD, Azimi H, and Montazeri A. Validity and Reliability of the Persian Version of the Baecke Habitual Physical Activity Questionnaire in Healthy Subjects. Asian J Sports Med. 2016;7(3).
[16] Krousel-Wood M, Islam T, Webber LS, Re R, Morisky DE, Muntner P. New Medication Adherence Scale versus Pharmacy Fill Rates in Hypertensive Seniors. Am J Manag Care. 2009;15(1):59.
[17] Johnson AEW, Pollard TJ, Shen L, Li-wei HL, Feng M, Ghassemi M, et al. MIMIC-III, A Freely Accessible Critical Care Database. Sci Data. 2016;3:160035.
[18] Baune BT, Aljeesh Y. The Association of Psychological Stress and Health-Related Quality of Life among Patients with Stroke and Hypertension in Gaza Strip. Ann Gen Psychiatry. 2006;5(1):6.
[19] Usherwood T. Encouraging Adherence to Long-term Medication. Aust Prescr. 2017;40(4):147.
[20] Joho AA. Factors Affecting Treatment Compliance among Hypertension Patients in Three District Hospitals—Dar es Salaam. Muhimbili University of Health and Allied Sciences; 2012.
[21] Hamer M. Adherence to Healthy Lifestyle in Hypertensive Patients: Ample Room for Improvement? J Hum Hypertens. 2010;24(9):559.
[22] Hashmi SK, Afridi MB, Abbas K, Sajwani RA, Saleheen D, Frossard PM, et al. Factors Associated with Adherence to Anti-hypertensive Treatment in Pakistan. PLoS One. 2007;2(3):e280.
[23] Kolesnik, Y.N., Yurina, N.A., Yurin, D.A., Danilova, A.A., Korotky, V.P., Ryzhov, V.A., Zenkin, A.S. (2018). Development of biohacking elements drawn from the example of cows under stress conditions. International Journal of Pharmaceutical Research, 10 (4), pp. 655-660.
[24] Mohammad irshad reza, divya goel, ziaur rahman, and shaikh aamer (2018): microRNA and RNA-binding proteins: the posttranscriptional regulators of foxo expression. Journal of Critical Reviews, 5 (2), 1-9. doi:10.22159/jcr.2018v5i2.24774
[25] Tiwari R, Tiwari G, Rai AK. "Self-Emulsifying Drug Delivery System: An Approach to Enhance Solubility." Systematic Reviews in Pharmacy 1.2 (2010), 133-140. Print. doi:10.4103/0975-8453.75055
Downloads
Published
Issue
Section
License
Copyright (c) 2020 AUTHOR
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
